Belite Bio (BLTE) Tops Q3 EPS by 22c
Belite Bio (NASDAQ: BLTE) reported Q3 EPS of ($0.28), $0.22 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.
Belite Bio (NASDAQ: BLTE) reported Q3 EPS of ($0.28), $0.22 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.